• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌切除术后高级别并发症对长期生存的影响:一项回顾性单中心队列研究。

Long-Term Survival Impact of High-Grade Complications after Liver Resection for Hepatocellular Carcinoma: A Retrospective Single-Centre Cohort Study.

机构信息

Department of Anaesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.

Department of Anaesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.

出版信息

Medicina (Kaunas). 2022 Apr 12;58(4):534. doi: 10.3390/medicina58040534.

DOI:10.3390/medicina58040534
PMID:35454372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9024755/
Abstract

: Although complications after liver resection for hepatic cancer are common, the long-term impact of these complications on oncological outcomes remains unclear. This study aimed to investigate the potential effect of high-grade postoperative complications on long-term mortality and cancer recurrence after surgical resection of hepatocellular carcinoma. : In a retrospective cohort study, patients undergoing curative liver resection for primary hepatocellular carcinoma between 2005 and 2016 were evaluated. The Clavien-Dindo (CD) grading system was used to classify patients into two groups of either high-grade complications (grade III or IV) or none or low-grade complications (grade 0 to II) within 30 days after surgery. The primary endpoint was all-cause mortality. Secondary endpoints were cancer-specific mortality and cancer recurrence. Weighted Cox proportional hazards regression models were used to calculate the adjusted hazard ratio (aHR) with a 95% confidence interval (CI) for the outcomes of interest. : A total of 1419 patients with a median follow-up time of 46.6 months were analysed. Among them, 93 (6.6%) developed high-grade complications after surgery. The most common complications were bile leakage ( = 30) in CD grade III and respiratory failure ( = 13) in CD grade IV. High-grade complications were significantly associated with all-cause mortality (aHR: 1.78, 95% CI: 1.55-2.06) and cancer-specific mortality (aHR: 1.34, 95% CI: 1.13-1.60), but not cancer recurrence (aHR: 0.92, 95% CI: 0.84-1.02). Independent influential factors for complications were sex, diabetes mellitus, clinically significant portal hypertension, oesophageal varices, multifocal cancer, intraoperative blood loss, and anaesthesia duration. : Patients who had high-grade postoperative complications had a greater risk of long-term mortality after liver resection for hepatocellular carcinoma. Prevention of postoperative complications may serve as an effective strategy for improving long-term survival.

摘要

尽管肝癌切除术后的并发症很常见,但这些并发症对肿瘤学结果的长期影响尚不清楚。本研究旨在探讨高级别术后并发症对肝癌根治性切除术后长期死亡率和癌症复发的潜在影响。

在一项回顾性队列研究中,评估了 2005 年至 2016 年间接受根治性肝切除术治疗原发性肝细胞癌的患者。采用 Clavien-Dindo(CD)分级系统将术后 30 天内发生高级别并发症(III 或 IV 级)或无或低级别并发症(0 至 II 级)的患者分为两组。主要终点为全因死亡率。次要终点为癌症特异性死亡率和癌症复发。使用加权 Cox 比例风险回归模型计算了感兴趣结局的调整后危险比(aHR)及其 95%置信区间(CI)。

共分析了 1419 例患者,中位随访时间为 46.6 个月。其中,93 例(6.6%)术后发生高级别并发症。最常见的并发症是 CD 分级 III 级的胆漏( = 30)和 CD 分级 IV 级的呼吸衰竭( = 13)。高级别并发症与全因死亡率(aHR:1.78,95%CI:1.55-2.06)和癌症特异性死亡率(aHR:1.34,95%CI:1.13-1.60)显著相关,但与癌症复发无关(aHR:0.92,95%CI:0.84-1.02)。并发症的独立影响因素为性别、糖尿病、临床显著门静脉高压、食管静脉曲张、多灶性癌症、术中出血量和麻醉持续时间。

发生高级别术后并发症的患者肝癌切除术后长期死亡率较高。预防术后并发症可能是提高长期生存率的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c2/9024755/97ffffc553c8/medicina-58-00534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c2/9024755/915eb35ae36c/medicina-58-00534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c2/9024755/97ffffc553c8/medicina-58-00534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c2/9024755/915eb35ae36c/medicina-58-00534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c2/9024755/97ffffc553c8/medicina-58-00534-g002.jpg

相似文献

1
Long-Term Survival Impact of High-Grade Complications after Liver Resection for Hepatocellular Carcinoma: A Retrospective Single-Centre Cohort Study.肝癌切除术后高级别并发症对长期生存的影响:一项回顾性单中心队列研究。
Medicina (Kaunas). 2022 Apr 12;58(4):534. doi: 10.3390/medicina58040534.
2
Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?肝细胞癌手术切除后早期手术并发症对急性和长期无复发生存的差异意义:合并症起作用吗?
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1045-1053. doi: 10.1097/MEG.0000000000000912.
3
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
4
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
5
Validation of hepatectomy for elderly patients with hepatocellular carcinoma.老年肝细胞癌患者肝切除术的验证
Ann Surg Oncol. 2015 Sep;22(9):3094-101. doi: 10.1245/s10434-014-4350-x. Epub 2015 Jan 13.
6
Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.影响基础肝病患者行大肝癌肝切除术后结局的危险因素。
World J Surg. 2011 Sep;35(9):2073-82. doi: 10.1007/s00268-011-1161-0.
7
Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma.术后并发症对肝癌根治性切除术后早期复发的预后价值。
Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):323-329. doi: 10.1016/j.hbpd.2018.03.016. Epub 2018 Mar 29.
8
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.肝细胞癌患者切除术后肝功能储备的恶化:发生率、危险因素及其与肝内肿瘤复发的关系。
World J Surg. 2004 Mar;28(3):258-62. doi: 10.1007/s00268-003-7182-6. Epub 2004 Feb 17.
9
Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: A propensity-score matched and structural equation modelling study.手术切除肝细胞癌术后并发症的预测因素及其对结局和生存的预后影响:倾向评分匹配和结构方程模型研究。
Eur J Surg Oncol. 2020 Sep;46(9):1756-1765. doi: 10.1016/j.ejso.2020.03.219. Epub 2020 Apr 2.
10
Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study.肝癌肝切除术后的术后发病率对长期肿瘤学预后不利:一项多中心观察性研究。
Eur J Surg Oncol. 2021 Oct;47(10):2551-2560. doi: 10.1016/j.ejso.2021.04.027. Epub 2021 Apr 26.

引用本文的文献

1
Constructing a neural network model based on tumor-infiltrating lymphocytes (TILs) to predict the survival of hepatocellular carcinoma patients.基于肿瘤浸润淋巴细胞(TILs)构建神经网络模型以预测肝细胞癌患者的生存情况。
PeerJ. 2025 Apr 23;13:e19351. doi: 10.7717/peerj.19351. eCollection 2025.

本文引用的文献

1
Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma.术后感染性并发症会恶化肝细胞癌根治性切除术后的长期生存率。
Ann Surg Oncol. 2022 Jan;29(1):315-324. doi: 10.1245/s10434-021-10565-2. Epub 2021 Aug 10.
2
Oncologic and long-term outcomes of enhanced recovery after surgery in cancer surgeries - a systematic review.癌症手术中术后加速康复的肿瘤学及长期预后——一项系统综述
World J Surg Oncol. 2021 Jun 29;19(1):191. doi: 10.1186/s12957-021-02306-2.
3
Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
术后并发症对肝癌切除术后长期生存的影响:系统评价和荟萃分析。
Ann Surg Oncol. 2021 Dec;28(13):8221-8233. doi: 10.1245/s10434-021-10317-2. Epub 2021 Jun 23.
4
A comparison of prognostic performance of perioperative inflammation markers in surgical resection for hepatocellular carcinoma.围手术期炎症标志物对肝癌手术切除预后性能的比较。
J Chin Med Assoc. 2021 Jun 1;84(6):614-622. doi: 10.1097/JCMA.0000000000000534.
5
Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country.老年肝细胞癌患者肝切除术后的短期和长期预后:来自一个发展中国家的229例病例分析
J Hepatocell Carcinoma. 2021 Mar 23;8:155-165. doi: 10.2147/JHC.S297296. eCollection 2021.
6
Epidural analgesia does not impact recurrence or mortality in patients after rectal cancer resection.硬膜外镇痛不会影响直肠癌切除术后患者的复发或死亡率。
Sci Rep. 2021 Jan 13;11(1):913. doi: 10.1038/s41598-020-79657-5.
7
Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.美国和中国台湾地区肝细胞癌的治疗模式和生存情况。
PLoS One. 2020 Oct 14;15(10):e0240542. doi: 10.1371/journal.pone.0240542. eCollection 2020.
8
The association of non-small cell lung cancer recurrence with allogenic blood transfusion after surgical resection: A propensity score analysis of 1,803 patients.非小细胞肺癌切除术后异体输血与复发的相关性:1803 例患者的倾向评分分析。
Eur J Cancer. 2020 Nov;140:45-54. doi: 10.1016/j.ejca.2020.09.004. Epub 2020 Oct 8.
9
Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer.术后不良事件与肺癌根治性切除术后的肿瘤复发相关。
Lung. 2020 Dec;198(6):973-981. doi: 10.1007/s00408-020-00395-6. Epub 2020 Oct 9.
10
Enhanced Recovery After Surgery (ERAS) Reduces Hospital Costs and Improve Clinical Outcomes in Liver Surgery: a Systematic Review and Meta-Analysis.加速康复外科(ERAS)可降低肝外科的住院费用并改善临床结局:系统评价和荟萃分析。
J Gastrointest Surg. 2020 Apr;24(4):918-932. doi: 10.1007/s11605-019-04499-0. Epub 2020 Jan 3.